Szita M, Gachályi B, Tornyossy M, Káldor A
Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):378-80.
Phenylbutazone pretreatment increases tolbutamide half-life, whereas tolbutamide pretreatment decreases phenylbutazone half-life in man. Clinically, phenylbutazone may enhance the hypoglycemic action of tolbutamide, and tolbutamide may reduce the therapeutic effect of phenylbutazone.
保泰松预处理可延长甲苯磺丁脲的半衰期,而甲苯磺丁脲预处理则会缩短保泰松在人体内的半衰期。临床上,保泰松可能会增强甲苯磺丁脲的降血糖作用,而甲苯磺丁脲可能会降低保泰松的治疗效果。